logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for GSK
Showkz
29 Aug 14 22:58:54
RT @MarketWatch: $GSK is the latest drug maker to come forward with its own experimental drug to treat Ebola: http://t.co/U0yIGQ5dJ9 http:/…
aleisiag
29 Aug 14 18:42:32
RT @FiercePharma: FDA clears Glaxo Ebola vaccine for speedy human trials http://t.co/2LmbkZishA $GSK #pharma
Florida Biotech
29 Aug 14 18:18:23
RT @Stocks_Biotech: [video] Human trials of Ebola Vaccine.. http://t.co/Cf5sTfeodQ $GSK #biotech #stocks
12Stocks.com Biotech
29 Aug 14 18:00:30
[video] Human trials of Ebola Vaccine.. http://t.co/Cf5sTfeodQ $GSK #biotech #stocks
Business Headlines
29 Aug 14 15:23:05
$GSK: [video] Human trials of Ebola Vaccine http://t.co/R1hLwroVKS http://t.co/K6jrxXZS0g
FDR Investment Group
29 Aug 14 14:44:09
A Quick Look Into GlaxoSmithKline ( $GSK ) http://t.co/HDIY4XROFm
TalkMarkets
29 Aug 14 13:52:57
Laidlaw's Yale Jen: #Biotech 101 For Buyers And Sellers $GSK $ISIS $RPRX $BIIB $ADMA $MSTX $PFE $GLYC http://t.co/dyKwIE1oik
William Gerber
29 Aug 14 13:41:08
@mickeythemous not sure why $NVS wouldn't wait to see Ph3 results and official close of $GSK deal (2015); NVS has free option at this point
Stockaholics
29 Aug 14 12:36:22
RSII shot up over 100% today! Major Update: http://t.co/GMnQioznZp $LFAP $GSK $ROX
TrendCache
29 Aug 14 12:30:42
#Trending #Biotech topics include $GSK, $MRK, #Pamocil #stocks #invest See more http://t.co/0Uk8oXnazd
Financial Updates
29 Aug 14 12:23:11
$GSK: [video] Human Trials of an Ebola Vaccine Launch http://t.co/tq6xhZo4MC http://t.co/uaD4Gdzs11
Donna Young
29 Aug 14 12:17:44
#Path2Cures $GSK Cardon: #pharma reduced R&D, so working w/ academics, creating companies/#jobs; but #NIH cuts damaging that enterprise
Yu Zhu
29 Aug 14 12:12:44
RT @SeekingAlpha: Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade http://t.co/MBAzJMwCLd $BCRX $FUJIY $GSK $IMMVF $NLNK …
Yu Zhu
29 Aug 14 12:12:30
RT @ianestepan: $GSK starting their Ebola vaccine trial in the next couple of weeks is a clear negative for $NLNK - hard to spin it positiv…
Media Sentiment
29 Aug 14 11:54:52
$GSK received a new alert. Find out why at http://t.co/5udYd0Ofs6 #stocks #daytrading #trading #mkt #NYSE #NASDAQ #markets 270
Market Int Center
29 Aug 14 11:52:58
GlaxoSmithKline PLC $GSK Showing Bearish Technicals With Support At $48.58 ( http://t.co/USRhBxdJGi )
TrendCache
29 Aug 14 11:42:07
#Trending #Biotech topics include $GSK, $AMGN, #Lanzohess #stocks #invest See more http://t.co/0Uk8oXnazd
Financial Buzz
29 Aug 14 11:29:40
August 29, 2014 LIVE from the NYSE This Week's Market News $SNE, $BKW $AMZN $RSH $MSFT $GSK $ATVI $RSH http://t.co/KXdr2j9tSd
Stock News Guru
29 Aug 14 11:23:05
$GSK: Why GlaxoSmithKline (GSK) Stock Is Gaining Today http://t.co/KhfxSdYvtA http://t.co/q9kWXyFE16
Tricia Dineen
29 Aug 14 11:19:15
@latebloomer4140 you are correct.WHO meeting convenes in Geneva 9/4-9/5 -- too bad WHO has not heard of GOTOMEETING ..#EBOLA, $GSK, $TKMR
Donna Young
29 Aug 14 11:14:37
#Path2Cures $GSK Cardon notes $GSK current work on #Ebola vaccine at @ECCures #pharma #NIH #FDA #NIAID
Craig Garbers
29 Aug 14 10:56:09
RT @SeekingAlpha: Is GlaxoSmithKline A Solid Long-Term Investment? http://t.co/HWTNA0IYJu $NVS $PFE $GSK
Dwayne Membrane
29 Aug 14 10:53:38
Added GlaxoSmithKline $GSK Oct 50 calls.
Seeking Alpha
29 Aug 14 10:46:08
Is GlaxoSmithKline A Solid Long-Term Investment? http://t.co/HWTNA0IYJu $NVS $PFE $GSK
TradeTexasBig
29 Aug 14 10:41:14
$GSK really nice, i was behind this since 46.. i dont think anyone else was excited then
Market News Desk
29 Aug 14 09:23:03
$GSK: Glaxo's Promacta Label Now Includes Severe Aplastic Anemia http://t.co/R78QEecRae http://t.co/teSLGcCcVA
Nigam Arora
29 Aug 14 09:15:16
USE CAUTION WHEN INVESTING IN EBOLA-RELATED STOCKS $TKMR $ITMN $GSK $BCRX $NLNK http://t.co/27jBP0Dr8Z
WallStreet
29 Aug 14 09:01:15
$GSK - GlaxoSmithKline plc (ADR) (NYSE:GSK) and NIH Pushing for an Ebola Vaccine - http://t.co/3InwkVPdkW
Donna Young
29 Aug 14 08:44:49
Senegal has confirmed 1st case of #Ebola #WHO #CDC #NIH #ZMapp $GSK $TKMR $BCRX
TalkMarkets
29 Aug 14 08:33:33
Give To Harvard? $PDYPF $DGRLY $TEVA $GSK $BVNKF $TCTZF $GBTZF $PT $BDRAF $OROCF $RBS $RDY $VE http://t.co/TN9CMoVLuq
Captain Future
29 Aug 14 07:03:27
$TKMR comon there are AT LEAST 4 companies in a bidding war for this - that was yesterday,today $GSK and $BCRX in favour to heal #Ebola
SCRIP Intelligence
29 Aug 14 06:55:31
RT @ScripDonnaDC: ICYMI: Ebola vaccine gets expedited green light http://t.co/4mBeK7OFqZ $GSK #NIH #NIAID #CDC #WHO #Ebola #pharma #biote…
SCRIP Intelligence
29 Aug 14 06:55:01
RT @ScripDonnaDC: #WHO: #Healthcare workers continue to be seriously affected in all countries by #Ebola, especially Liberia & Nigeria #CDC…
SCRIP Intelligence
29 Aug 14 06:54:55
RT @ScripDonnaDC: #WHO: Liberia capacity to cope w/ increasing #Ebola caseload remains dramatically low, especially in Monrovia #CDC #pharm…
Day Trade Alerts
29 Aug 14 06:51:35
via #AlertTrade Price Action Alert $GSK - GLAXOSMITHKLINE #stocks #intraday http://t.co/VS8RO1bzXJ
Derek Pietro
29 Aug 14 05:29:26
Stocks ready to breakout of trading ranges $SFTBY $F $S $GSK $TSN $MTLS #marketaction
Biz News Pioneer
29 Aug 14 05:23:05
$GSK: Tekmira Surges On Takeover Rumors http://t.co/ysv2p45D1k http://t.co/LDncG5QDbr
Lucretia
29 Aug 14 05:00:21
$GSK GSK's Promacta Gets Supplemental Approval From FDA http://t.co/zvyJMbTZXP
Donna Young
29 Aug 14 04:56:33
#WHO: #Healthcare workers continue to be seriously affected in all countries by #Ebola, especially Liberia & Nigeria #CDC #NIH $GSK #ZMapp
Donna Young
29 Aug 14 04:52:19
#WHO: Liberia capacity to cope w/ increasing #Ebola caseload remains dramatically low, especially in Monrovia #CDC #pharma #ZMapp $GSK $TKMR
David Schull
29 Aug 14 04:26:34
RT @reutersBenHir: #GSK #Ebola vaccine fast-tracked into U.S., UK and African trials http://t.co/0BtpHdYNND $GSK
Stock Market Monitor
29 Aug 14 04:23:03
$GSK: Here’s Why You Need GlaxoSmithKline plc In Your Portfolio http://t.co/McBsHSy2V6 http://t.co/Q5NL519WVV
Industry Pharmacists
29 Aug 14 04:09:30
RT @fwpharma: ICYMI: Clinical study of @GSK's #Ebola vaccine set to start http://t.co/MT2EENlPel $GSK #pharma
Donna Young
29 Aug 14 03:59:51
ICYMI: Ebola vaccine gets expedited green light http://t.co/4mBeK7OFqZ $GSK #NIH #NIAID #CDC #WHO #Ebola #pharma #biotech #biopharma
Never Forget Bot
29 Aug 14 03:46:38
Never Forget: Clinical study of .GSK's #Ebola vaccine set to start http://t.co/yvmYZ9xVj5 $GSK #pharma
FirstWord Pharma
29 Aug 14 03:45:32
ICYMI: Clinical study of @GSK's #Ebola vaccine set to start http://t.co/MT2EENlPel $GSK #pharma
Matt
29 Aug 14 03:29:10
$TKMR $SRPT $BCRX $GSK Ebola Vaccine Stocks http://t.co/8ofhZ0s71x
Nicola Low
29 Aug 14 03:08:52
RT @MsTriciaD: @AdotKim $GSK is vaccine - given to prevent Ebola ... $TKMR is a potential cure
TalkMarkets
29 Aug 14 02:36:44
Laidlaw's Yale Jen: #Biotech 101 For Buyers And Sellers $GSK $ISIS $RPRX $BIIB $ADMA $MSTX $PFE $GLYC http://t.co/9AjHJ2vG4u
Gotham City Capital
29 Aug 14 02:31:21
RT @MsTriciaD: @AdotKim $GSK is vaccine - given to prevent Ebola ... $TKMR is a potential cure
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.